Español (soon!) - July 29, 2010 CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.   CMEonHIV exclusive !   Antiretroviral Therapy in Naïve Patients The QUAD and Time Studies tested various regimens in ARV naïve patients. The QUAD Study tested a 4 drug regimen against a 3 drug regimen: TZV+SQV/R vs CBV+SQV/R. The Time Study looked at (TZV/EFV 48 weeks) vs (TZV/EFV 24 weeks followed by TZV 24 weeks) vs TZV 48 weeks. New data from these studies will be discussed here, as well as data on the time... HIV/HCV Co-infection Although the EUROSIDA Study showed no role of HCV in accelerating the progression of AIDS, there was a rise observed in liver related deaths in HIV/HCV co-infected patients. Clinical data on peg alpha 2a plus Ribavirin (PRESCO Study), and peg alpha 2b plus Ribavirin (Santos et al) in treatment of HIV/HCV co-infected patients will be discussed here, as well as new... Management of ART-Experienced and Salvage Patients In this presentation Dr Fraser will discuss the evolution of HIV drug resistance in relation to replicative capacity and viremia based on a clinical cohort study (Deeks et al); and give a review of cohort studies on...   PubMed: Latest Scientific Publication (NCBI: db=PubMed; RSS Feed) 2010-07-24 Enhanced Induction of HIV-specific Cytotoxic T Lymphocytes by Dendritic... 2010-07-24 Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a... 2010-07-24 Development of an in vitro dual-chamber model of the female genital tract as a... 2010-07-24 The association between penis size and sexual health among men who have sex with... 2010-07-23 ADS-J1 inhibits HIV-1 entry by interacting with gp120 and does not block the... 2010-07-23 High frequency of lamivudine resistance mutations in Brazilian patients co-infected... 2010-07-23 Enhanced Induction of HIV-specific Cytotoxic T Lymphocytes by Dendritic... 2010-07-23 The Renaissance in HIV Vaccine Development -- Future Directions. 2010-07-23 Envelope glycans of immunodeficiency virions are almost entirely oligomannose... 2010-07-23 Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and... 2010-07-23 SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on... 2010-07-23 XMRV: does this virus hold the key to myalgic encephalomyelitis/CFS? 2010-07-23 Cd4+ and cd4- cd1d-restricted natural killer T cells in perinatally HIV-1 infected... 2010-07-23 Modulators of Multidrug Resistance Associated Proteins in the Management of... 2010-07-23 Conjunctival squamous cell carcinoma. 2010-07-23 AIDS-related Kaposi's sarcoma of the gastrointestinal tract. 2010-07-23 The phenylpropanoids of Aster flaccidus. 2010-07-23 HIV infection transmission; +22 new citations 2010-07-23 High frequency of lamivudine resistance mutations in Brazilian patients co-infected... 2010-07-23 Antimycobacterial activity of usnic acid against resistant and susceptible strains...   1 2 3 4 5 6 7 8     Login   Username :   Password :       Lost your password?   Search our Database   Find the information that you are looking for in over +3000 resources.   web cmeonhiv.com   HONcode   This site subscribes to the HONcode principles of the Health On the Net Foundation. The information provided on this web site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website hosts Google sponsored ads and links. We do not control Google ads content and our editorial content is free of any commercial influence.

ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

Copyright @ 2002-2010 E-MedHosting.com. All rights reserved.  Disclaimer  
Powered by Multiwebcast - webcast services Last update: 2010-07-22

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR
THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.